FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119580095> ?p ?o ?g. }

• W3119580095 abstract "Abstract:: In December 2019, in Wuhan, China, an outbreak of a respiratory disease was reported, and the causative agent of which was discovered to be the new coronavirus. This disease spread rapidly around the world, and in March 2020, the WHO declared a state of pandemic. According to the WHO situation in October report, more than 41,570.883 were affected, and 1,134.940 deaths had occurred. Thus, the urgency to find therapeutic targets to prevent viral replication and a vaccine to protect against the disease became a great challenge for researchers around the world. A French group began using, in patients, a drug that had already been approved for human use, hydroxychloroquine (HQ) alone or in combination with azithromycin. The use of a drug already approved by regulatory agencies can enable treatment strategies to be put in place rapidly; however, even though in vitro may indicate success, this is not always guaranteed. For HQ, some studies have shown a satisfactory response in patients, while in many others, the result was not positive and patients actually died. Furthermore, many adverse effects of HQ have been described. In this review, we will briefly discuss how this therapy became an option for the treatment of SARS-CoV-2 infection. We will address the use of HQ in different pathologies and COVID-19 specifically; describing the doses used, as well as the main adverse effects. The take-home message is that more efforts are still required to conclude the efficacy of HQ against COVID-19, however, most of the studies carried out currently are showing that the use of HQ does not bring benefits during treatment of COVID-19." @default.
• W3119580095 created "2021-01-18" @default.
• W3119580095 creator A5005425946 @default.
• W3119580095 creator A5006483982 @default.
• W3119580095 creator A5052063647 @default.
• W3119580095 creator A5054367986 @default.
• W3119580095 creator A5061697197 @default.
• W3119580095 creator A5083470477 @default.
• W3119580095 date "2021-07-01" @default.
• W3119580095 modified "2023-10-09" @default.
• W3119580095 title "COVID-19 and the Challenges of Chemotherapy: The Failure Case of Hydroxychloroquine in the Clinical Treatment of SARS-CoV-2 Infection" @default.
• W3119580095 cites W1608798960 @default.
• W3119580095 cites W2012505332 @default.
• W3119580095 cites W2015030623 @default.
• W3119580095 cites W2018534682 @default.
• W3119580095 cites W2020619078 @default.
• W3119580095 cites W2025265534 @default.
• W3119580095 cites W2034693873 @default.
• W3119580095 cites W2058069729 @default.
• W3119580095 cites W2058252397 @default.
• W3119580095 cites W2058732353 @default.
• W3119580095 cites W2075689919 @default.
• W3119580095 cites W2087251383 @default.
• W3119580095 cites W2088239064 @default.
• W3119580095 cites W2095923455 @default.
• W3119580095 cites W2114708650 @default.
• W3119580095 cites W2115555188 @default.
• W3119580095 cites W2128830870 @default.
• W3119580095 cites W2131848809 @default.
• W3119580095 cites W2158073262 @default.
• W3119580095 cites W2164687312 @default.
• W3119580095 cites W2343647993 @default.
• W3119580095 cites W2417464115 @default.
• W3119580095 cites W2560774983 @default.
• W3119580095 cites W2580356750 @default.
• W3119580095 cites W2600076359 @default.
• W3119580095 cites W2745820823 @default.
• W3119580095 cites W2785039139 @default.
• W3119580095 cites W2806330066 @default.
• W3119580095 cites W2889530678 @default.
• W3119580095 cites W2908895954 @default.
• W3119580095 cites W2912583876 @default.
• W3119580095 cites W2915527082 @default.
• W3119580095 cites W2937350578 @default.
• W3119580095 cites W2939412530 @default.
• W3119580095 cites W2941156143 @default.
• W3119580095 cites W2958140786 @default.
• W3119580095 cites W2971662549 @default.
• W3119580095 cites W3003217347 @default.
• W3119580095 cites W3003752833 @default.
• W3119580095 cites W3004348779 @default.
• W3119580095 cites W3004709581 @default.
• W3119580095 cites W3008884284 @default.
• W3119580095 cites W3009577418 @default.
• W3119580095 cites W3009912996 @default.
• W3119580095 cites W3010126769 @default.
• W3119580095 cites W3010673910 @default.
• W3119580095 cites W3010930696 @default.
• W3119580095 cites W3010992334 @default.
• W3119580095 cites W3011127849 @default.
• W3119580095 cites W3011483298 @default.
• W3119580095 cites W3011680753 @default.
• W3119580095 cites W3012565918 @default.
• W3119580095 cites W3013093478 @default.
• W3119580095 cites W3013152614 @default.
• W3119580095 cites W3013174684 @default.
• W3119580095 cites W3013232761 @default.
• W3119580095 cites W3013450525 @default.
• W3119580095 cites W3013630838 @default.
• W3119580095 cites W3013667078 @default.
• W3119580095 cites W3013800395 @default.
• W3119580095 cites W3013899502 @default.
• W3119580095 cites W3014420687 @default.
• W3119580095 cites W3014504912 @default.
• W3119580095 cites W3015059505 @default.
• W3119580095 cites W3015281372 @default.
• W3119580095 cites W3015446564 @default.
• W3119580095 cites W3016288338 @default.
• W3119580095 cites W3016436258 @default.
• W3119580095 cites W3016808276 @default.
• W3119580095 cites W3016829049 @default.
• W3119580095 cites W3017010629 @default.
• W3119580095 cites W3017239581 @default.
• W3119580095 cites W3017249564 @default.
• W3119580095 cites W3020239101 @default.
• W3119580095 cites W3023082818 @default.
• W3119580095 cites W3023346879 @default.
• W3119580095 cites W3025795175 @default.
• W3119580095 cites W3025972894 @default.
• W3119580095 cites W3027680906 @default.
• W3119580095 cites W3044118599 @default.
• W3119580095 cites W3044416430 @default.
• W3119580095 cites W3045220852 @default.
• W3119580095 cites W3091868035 @default.
• W3119580095 cites W4240833335 @default.
• W3119580095 doi "https://doi.org/10.2174/2666796702999210112202907" @default.
• W3119580095 hasPublicationYear "2021" @default.
• W3119580095 type Work @default.
• W3119580095 sameAs 3119580095 @default.
• W3119580095 citedByCount "0" @default.

• next